Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds in pharmaceutical synthesis. Its protected boronic acid group enhances stability and selectivity during multi-step reactions. Commonly employed in the development of pyrazole-containing drug candidates, especially in oncology and anti-inflammatory agents. The silyl-protected ether group allows for mild deprotection conditions, making it suitable for complex molecule assembly.